Quantum Private Wealth’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,070
Closed -$461K 190
2024
Q2
$461K Sell
4,070
-1,746
-30% -$221K 0.16% 109
2024
Q1
$807K Sell
5,816
-1,193
-17% -$150K 0.3% 70
2023
Q4
$870K Sell
7,009
-93
-1% -$9.5K 0.36% 67
2023
Q3
$663K Sell
7,102
-100
-1% -$11.3K 0.32% 74
2023
Q2
$926K Sell
7,202
-602
-8% -$72.8K 0.43% 55
2023
Q1
$907K Buy
7,804
+234
+3% +$26.2K 0.49% 46
2022
Q4
$857K Sell
7,570
-599
-7% -$65.8K 0.54% 39
2022
Q3
$657K Buy
8,169
+4,091
+100% +$346K 0.41% 56
2022
Q2
$303K Buy
4,078
+474
+13% +$43.3K 0.18% 121
2022
Q1
$460K Hold
3,604
0.2% 110
2021
Q4
$483K Buy
+3,604
New +$518K 0.18% 115

Other funds holding DXCM

Quantum Private Wealth's DXCM Position: Q3 2024 in Review

Quantum Private Wealth sold out of DexCom (DXCM) in Q3 2024, closing a stake of 4,070 shares — an estimated $461K sold.

Quantum Private Wealth first reported a position in DXCM in Q4 2021 and held it in 11 quarters. The position peaked at $926K in Q2 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Quantum Private Wealth reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Quantum Private Wealth sold 4,070 DexCom shares in Q3 2024, an estimated $461K.
  • Quantum Private Wealth first reported a position in DexCom in Q4 2021 and held it in 11 quarters.
  • Quantum Private Wealth's DexCom position peaked at $926K in Q2 2023.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Quantum Private Wealth's 13F filing for Q3 2024, filed 31 Oct 2024.